The global ultrasound gel market size is expected to reach USD 126.2 Million in 2030 and register a revenue CAGR of 3.4% over the forecast period, according to a latest report by Reports and Data. Rapid increase in the world population, implying increase in number of pregnancies throughout the world, and increasing adoption of ultrasound gels in ultrasound for pregnant women are expected to drive market revenue growth during the forecast period. Increasing demand for ultrasound gels to manufacture ultrasound scan of the developing foetus is expected to boost growth of the ultrasound gel market in the near future. Increasing demand for sterile as well as non-sterile ultrasound gels in the medical sector has led to increased manufacture of ultrasound gels. Non-sterile ultrasound gel is widely used across all hospitals for performing ultrasound owing to its easy availability and low cost. Although non-sterile, the gel is non-invasive and not harmful, and can be used by all patients unless the region to be scanned has a cut or a wound. This is expected to drive revenue growth of the market in the near future. Increasing demand for non-sterile gels owing to abundant availability and high number of manufacturers is expected to drive market revenue growth. Moreover, increasing adoption of ultrasound gels owing to its property of conducting ultrasonic waves to produce clear images of inaccessible internal organs has led to increased demand for ultrasound gel and is expected to drive revenue growth of the market.
However, challenges in using non-sterile gels in patients who are prone to infection or have cuts and wounds on the region to be examined are some factors that could hamper market revenue growth during the forecast period. In such situations, maintaining an aseptic condition for the patient is difficult as non-sterile gels are prone to contamination. This leads to a challenge in using the same ultrasound gel for all patients, which is expected to restrain the market revenue growth.
Market Overview:
The pharma and healthcare industry is at a crossroads. Patients are benefiting from the promise of cell and gene therapies; uncommon diseases that were previously thought to be incurable are on the verge of finding true treatments. Artificial intelligence (AI) and machine-learning technologies are creating hopes that therapy discovery and development would be more innovative, as well as faster and cheaper. Manufacturing, the supply chain, and the entire healthcare ecosystem all have the potential to benefit from data-driven initiatives. Consumer attitudes and behaviours are shifting in a variety of ways, from growing use of technology and willingness to share data to an interest in using tools to make prescription and treatment decisions. Such factors will drive pharma and healthcare market growth in the coming years.
As part of our quantitative analysis, we have provided regional market forecasts by type and application, market sales forecasts and estimates by type, application and region by 2030, and global sales and production forecasts and estimates for Ultrasound Gel by 2030. For the qualitative analysis, we focused on political and regulatory scenarios, component benchmarking, technology landscape, important market topics as well as industry landscape and trends.
We have also focused on technological lead, profitability, company size, company valuation in relation to the industry and analysis of products and applications in relation to market growth and market share.
The Ultrasound Gel report contains data based on rigorous primary and secondary school studies using research best practices. The report contains exhaustive information that will allow you to assess each segment of the Ultrasound Gel market. This report has been prepared considering various aspects of market research and analysis. It includes market size estimates, market dynamics, and company and market best practices. Entry marketing strategy, positioning, segmentation, competitive landscape, and economic forecasts. Industry-specific technology solutions, roadmap analysis, alignment with key purchasing criteria, in-depth benchmarking of vendor products
Key Players covered in this report are:
Sonotec GmbH, Parker Laboratories Inc., Eco-Med Pharmaceutical Inc., National Therapy Products Inc., HR Pharmaceuticals Inc., Anita Medical Systems Pvt. Ltd., Megro GmbH & Co. KG, Sonogel Vertiebs GmbH, Katecho, LLC, and Geltek-Medica Ltd.
Type Outlook (Revenue, USD Million; 2019-2030)
- Sterile
- Non-sterile
Application Outlook (Revenue, USD Million; 2019-2030)
- Pregnancy Ultrasound
- Organ Ultrasound
- Others
Geographic Segment Covered in the Report:
• North America (USA and Canada)
• Europe (UK, Germany, France and the rest of Europe)
• Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)
• Latin America (Brazil, Mexico, and the rest of Latin America)
• Middle East and Africa (GCC and rest of the Middle East and Africa)
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/5011
Thank you for reading the research report on global Ultrasound Gel market. Kindly contact us to know more about the customization feature and our team will offer the best suited report as per your requirement.
Browse More Report:
Digital Therapeutics Market @ https://www.biospace.com/article/digital-therapeutics-market-size-to-reach-usd-1-31-billion-by-2028-reports-and-data/
Left Ventricular Assist Device (LVAD) Market @ https://www.biospace.com/article/left-ventricular-assist-device-lvad-market-to-reach-usd-2-87-billion-by-2028-reports-and-data/
Diabetic Retinopathy Market @ https://www.biospace.com/article/diabetic-retinopathy-market-size-to-reach-usd-15-01-billion-in-2028/
Point of Care (PoC) Diagnostics Market @ https://www.biospace.com/article/rise-in-government-initiatives-to-address-overweight-issues-and-increasing-development-of-advanced-and-effective-weight-management-treatments-are-among-the-key-factors-contributing-to-market-growth/
Antiviral Drugs Market @ https://www.biospace.com/article/antiviral-drugs-market-size-to-reach-usd-77-07-billion-in-2028-reports-and-data/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
0 Comments
Post a Comment